Overview
MetaNovas AI-driven molecular, new materials, and bioactive ingredient research and development
Funding
Amounts as reported; USD estimates shown only when they matchListed 3 funding records.
No chartable funding estimates yet.
3 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| May 26, 2026 | Undisclosed · Equity | 深圳富华私募股权天使投资合伙企业（有限合伙） | No source link |
Evidence Yuanxing Zhiyao Metanovas completes equity financing with an undisclosed amountOn 2026/5/26, Xiniu Data reported that Yuanxing Zhiyao Metanovas completed equity financing for an undisclosed amount. The investor was Shenzhen Fuhua Private Equity Angel Investment Partnership (Limited Partnership). The company develops anti-aging and metabolic drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Mar 9, 2026 | Undisclosed · Series A+ | Gaoling Capital, 富华资本, 雅颜生物 | No source link |
Evidence Yuanxingzhiyao Metanovas completes Series A+ financingOn 2026-03-09, according to Xiniu Data, Yuanxingzhiyao Metanovas completed Series A+ financing for an undisclosed amount. Investors were Gaoling Capital, Yayan Biotechnology, Fuhua Capital, Daishumama. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Dec 2, 2024 | Undisclosed · Series A | Gaoling Venture Capital, 宝顶创投基金, 若羽臣 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 3 valuation records.
No chartable valuation estimates yet.
3 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| May 26, 2026 | — · Equity | 深圳富华私募股权天使投资合伙企业（有限合伙） | No source link |
Evidence Yuanxing Zhiyao Metanovas completes equity financing with an undisclosed amountOn 2026/5/26, Xiniu Data reported that Yuanxing Zhiyao Metanovas completed equity financing for an undisclosed amount. The investor was Shenzhen Fuhua Private Equity Angel Investment Partnership (Limited Partnership). The company develops anti-aging and metabolic drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Mar 9, 2026 | — · Series A+ | Gaoling Capital, 富华资本, 雅颜生物 | No source link |
Evidence Yuanxingzhiyao Metanovas completes Series A+ financingOn 2026-03-09, according to Xiniu Data, Yuanxingzhiyao Metanovas completed Series A+ financing for an undisclosed amount. Investors were Gaoling Capital, Yayan Biotechnology, Fuhua Capital, Daishumama. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Dec 2, 2024 | — · Series A | Gaoling Venture Capital, 宝顶创投基金, 若羽臣 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
MetaNovas AI驱动分子、新材料与生物活性原料研发